CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 119 enrolled
Drug / intervention
CMR examinationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03545672
NCT03545672N/ACompleted

EARLY Identification of MYOcardial Impairment in Primary Biliary Cholangitis

RenJi Hospital·observational·Posted Jun 4, 2018·Updated Aug 9, 2024

In Brief

An observational study evaluating CMR examination for Primary Biliary Cholangitis and Cardiovascular Abnormalities. Completed, enrolled 119 participants across 1 site.

Detailed Summary

Primary biliary cholangitis (PBC) is a chronic inflammatory liver disease leading to cirrhosis. Researches reported patients with PBC may involve abnormalities on skeleton, thyroid and exocrine glands. However, whether this autoimmune disease would cause cardiac impairment is scarcely investigated. Cardiovascular Magnetic Resonance(CMR) is recently developed as a reliable modality to evaluate the cardiac tissue characteristics and functions. This study aims to investigate the cardiac status in PBC patients based on CMR.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 4, 2018
Enrollment StartOct 23, 2017
Primary CompletionAug 15, 2019
Study CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.1 years ago

Interventions

CMR examinationother

After recruiting participants and collecting the baseline information, a CMR scan and a post-processed imaging procedure will be carried on in order to detect the cardiac impairment.